Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer Disease.

Ossenkoppele R, Lyoo CH, Jester-Broms J, Sudre CH, Cho H, Ryu YH, Choi JY, Smith R, Strandberg O, Palmqvist S, Kramer J, Boxer AL, Gorno-Tempini ML, Miller BL, La Joie R, Rabinovici GD, Hansson O.

JAMA Neurol. 2020 Feb 24. doi: 10.1001/jamaneurol.2019.5154. [Epub ahead of print]

PMID:
32091549
2.

Customized FreeSurfer-based brain atlas for diffeomorphic anatomical registration through exponentiated lie algebra tool.

Baek MS, Cho H, Ryu YH, Lyoo CH.

Ann Nucl Med. 2020 Feb 22. doi: 10.1007/s12149-020-01445-y. [Epub ahead of print]

PMID:
32088883
3.

Guidelines for the content and format of PET brain data in publications and archives: A consensus paper.

Knudsen GM, Ganz M, Appelhoff S, Boellaard R, Bormans G, Carson RE, Catana C, Doudet D, Gee AD, Greve DN, Gunn RN, Halldin C, Herscovitch P, Huang H, Keller SH, Lammertsma AA, Lanzenberger R, Liow JS, Lohith TG, Lubberink M, Lyoo CH, Mann JJ, Matheson GJ, Nichols TE, Nørgaard M, Ogden T, Parsey R, Pike VW, Price J, Rizzo G, Rosa-Neto P, Schain M, Scott PJ, Searle G, Slifstein M, Suhara T, Talbot PS, Thomas A, Veronese M, Wong DF, Yaqub M, Zanderigo F, Zoghbi S, Innis RB.

J Cereb Blood Flow Metab. 2020 Feb 16:271678X20905433. doi: 10.1177/0271678X20905433. [Epub ahead of print] No abstract available.

PMID:
32065076
4.

Low thalamic monoamine transporter availability is related to excessive daytime sleepiness in early Parkinson's disease.

Yoo SW, Oh YS, Ryu DW, Lee KS, Lyoo CH, Kim JS.

Neurol Sci. 2019 Dec 23. doi: 10.1007/s10072-019-04206-6. [Epub ahead of print]

PMID:
31872354
5.

Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer's disease.

Ossenkoppele R, Lyoo CH, Sudre CH, van Westen D, Cho H, Ryu YH, Choi JY, Smith R, Strandberg O, Palmqvist S, Westman E, Tsai R, Kramer J, Boxer AL, Gorno-Tempini ML, La Joie R, Miller BL, Rabinovici GD, Hansson O.

Alzheimers Dement. 2020 Feb;16(2):335-344. doi: 10.1016/j.jalz.2019.08.201. Epub 2020 Jan 4.

6.

Application of an amyloid and tau classification system in subcortical vascular cognitive impairment patients.

Jang H, Kim HJ, Park S, Park YH, Choe Y, Cho H, Lyoo CH, Yoon U, Lee JS, Kim Y, Kim SJ, Kim JP, Jung YH, Ryu YH, Choi JY, Moon SH, Seong JK, DeCarli C, Weiner MW, Lockhart SN, Cho SH, Na DL, Seo SW.

Eur J Nucl Med Mol Imaging. 2020 Feb;47(2):292-303. doi: 10.1007/s00259-019-04498-y. Epub 2019 Aug 31.

PMID:
31471715
7.

THK5351 and flortaucipir PET with pathological correlation in a Creutzfeldt-Jakob disease patient: a case report.

Kim HJ, Cho H, Park S, Jang H, Ryu YH, Choi JY, Moon SH, Oh SJ, Oh M, Na DL, Lyoo CH, Kim EJ, Seeley WW, Kim JS, Choi KC, Seo SW.

BMC Neurol. 2019 Aug 29;19(1):211. doi: 10.1186/s12883-019-1434-z.

8.

Gender difference in the effect of uric acid on striatal dopamine in early Parkinson's disease.

Oh YS, Kim JS, Yoo SW, Hwang EJ, Lyoo CH, Lee KS.

Eur J Neurol. 2020 Feb;27(2):258-264. doi: 10.1111/ene.14070. Epub 2019 Sep 12.

PMID:
31446637
9.

A Patient with Neuroferritinopathy Presenting with Juvenile-Onset Voice Tremor.

Park CW, Kim NY, Kim YJ, Song SK, Lyoo CH.

J Mov Disord. 2020 Jan;13(1):66-68. doi: 10.14802/jmd.19038. Epub 2019 Aug 9. No abstract available.

10.

"Depressed" caudate and ventral striatum dopamine transporter availability in de novo Depressed Parkinson's disease.

Yoo SW, Oh YS, Hwang EJ, Ryu DW, Lee KS, Lyoo CH, Kim JS.

Neurobiol Dis. 2019 Dec;132:104563. doi: 10.1016/j.nbd.2019.104563. Epub 2019 Aug 1.

11.

Effect of polygenic load on striatal dopaminergic deterioration in Parkinson disease.

Lee MJ, Pak K, Kim JH, Kim YJ, Yoon J, Lee J, Lyoo CH, Park HJ, Lee JH, Jung NY.

Neurology. 2019 Aug 13;93(7):e665-e674. doi: 10.1212/WNL.0000000000007939. Epub 2019 Jul 9.

PMID:
31289143
12.

Progressive Tau Accumulation in Alzheimer Disease: 2-Year Follow-up Study.

Cho H, Choi JY, Lee HS, Lee JH, Ryu YH, Lee MS, Jack CR Jr, Lyoo CH.

J Nucl Med. 2019 Nov;60(11):1611-1621. doi: 10.2967/jnumed.118.221697. Epub 2019 Mar 29.

PMID:
30926651
13.

Striatal dopamine activity and myocardial 123I-metaiodobenzylguanidine uptake in early Parkinson's disease.

Oh YS, Kim JS, Yoo SW, Hwang EJ, Lyoo CH, Lee KS.

Parkinsonism Relat Disord. 2019 Jun;63:156-161. doi: 10.1016/j.parkreldis.2019.02.012. Epub 2019 Feb 14.

PMID:
30796009
14.

Functional connectivity associated with tau levels in ageing, Alzheimer's, and small vessel disease.

Franzmeier N, Rubinski A, Neitzel J, Kim Y, Damm A, Na DL, Kim HJ, Lyoo CH, Cho H, Finsterwalder S, Duering M, Seo SW, Ewers M; Alzheimer’s Disease Neuroimaging Initiative.

Brain. 2019 Apr 1;142(4):1093-1107. doi: 10.1093/brain/awz026.

PMID:
30770704
15.

Novel Ferritin Light Chain Gene Mutation in a Korean Patient with Neuroferritinopathy.

Yoon SH, Kim NY, Kim YJ, Lyoo CH.

J Mov Disord. 2019 Jan;12(1):63-65. doi: 10.14802/jmd.18062. Epub 2019 Jan 30. No abstract available.

16.

Automatic Extraction of a Reference Region for the Noninvasive Quantification of Translocator Protein in Brain Using 11C-PBR28.

Zanotti-Fregonara P, Kreisl WC, Innis RB, Lyoo CH.

J Nucl Med. 2019 Jul;60(7):978-984. doi: 10.2967/jnumed.118.222927. Epub 2019 Jan 17.

17.

18F-flortaucipir uptake patterns in clinical subtypes of primary progressive aphasia.

Cho H, Kim HJ, Choi JY, Ryu YH, Lee MS, Na DL, Seo SW, Lyoo CH.

Neurobiol Aging. 2019 Mar;75:187-197. doi: 10.1016/j.neurobiolaging.2018.11.017. Epub 2018 Nov 23.

PMID:
30594046
18.

Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders.

Ossenkoppele R, Rabinovici GD, Smith R, Cho H, Schöll M, Strandberg O, Palmqvist S, Mattsson N, Janelidze S, Santillo A, Ohlsson T, Jögi J, Tsai R, La Joie R, Kramer J, Boxer AL, Gorno-Tempini ML, Miller BL, Choi JY, Ryu YH, Lyoo CH, Hansson O.

JAMA. 2018 Sep 18;320(11):1151-1162. doi: 10.1001/jama.2018.12917.

19.

Decreased Cannabinoid CB1 Receptors in Male Tobacco Smokers Examined With Positron Emission Tomography.

Hirvonen J, Zanotti-Fregonara P, Gorelick DA, Lyoo CH, Rallis-Frutos D, Morse C, Zoghbi SS, Pike VW, Volkow ND, Huestis MA, Innis RB.

Biol Psychiatry. 2018 Nov 15;84(10):715-721. doi: 10.1016/j.biopsych.2018.07.009. Epub 2018 Jul 21.

20.

PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects.

Richards EM, Zanotti-Fregonara P, Fujita M, Newman L, Farmer C, Ballard ED, Machado-Vieira R, Yuan P, Niciu MJ, Lyoo CH, Henter ID, Salvadore G, Drevets WC, Kolb H, Innis RB, Zarate CA Jr.

EJNMMI Res. 2018 Jul 3;8(1):57. doi: 10.1186/s13550-018-0401-9.

21.

Impaired finger dexterity and nigrostriatal dopamine loss in Parkinson's disease.

Lee SH, Lee MJ, Lyoo CH, Cho H, Lee MS.

J Neural Transm (Vienna). 2018 Sep;125(9):1333-1339. doi: 10.1007/s00702-018-1901-5. Epub 2018 Jul 3.

PMID:
29971496
22.

Striatal dopamine uptake and olfactory dysfunction in patients with early Parkinson's disease.

Oh YS, Kim JS, Hwang EJ, Lyoo CH.

Parkinsonism Relat Disord. 2018 Nov;56:47-51. doi: 10.1016/j.parkreldis.2018.06.022. Epub 2018 Jun 14.

PMID:
29925486
23.

Assessment of Extent and Role of Tau in Subcortical Vascular Cognitive Impairment Using 18F-AV1451 Positron Emission Tomography Imaging.

Kim HJ, Park S, Cho H, Jang YK, San Lee J, Jang H, Kim Y, Kim KW, Ryu YH, Choi JY, Moon SH, Weiner MW, Jagust WJ, Rabinovici GD, DeCarli C, Lyoo CH, Na DL, Seo SW.

JAMA Neurol. 2018 Aug 1;75(8):999-1007. doi: 10.1001/jamaneurol.2018.0975.

24.

Predicted sequence of cortical tau and amyloid-β deposition in Alzheimer disease spectrum.

Cho H, Lee HS, Choi JY, Lee JH, Ryu YH, Lee MS, Lyoo CH.

Neurobiol Aging. 2018 Aug;68:76-84. doi: 10.1016/j.neurobiolaging.2018.04.007. Epub 2018 Apr 17.

PMID:
29751288
25.

Increased Uptake of AV-1451 in a Subacute Infarction Lesion.

Cho SH, Cho H, Park S, Ryu YH, Choi JY, Lyoo CH, Na DL, Seo SW, Kim HJ.

Yonsei Med J. 2018 Jun;59(4):563-565. doi: 10.3349/ymj.2018.59.4.563.

26.

Predominant subcortical accumulation of 18F-flortaucipir binding in behavioral variant frontotemporal dementia.

Cho H, Seo SW, Choi JY, Lee HS, Ryu YH, Lee MS, Na DL, Kim HJ, Lyoo CH.

Neurobiol Aging. 2018 Jun;66:112-121. doi: 10.1016/j.neurobiolaging.2018.02.015. Epub 2018 Feb 21.

PMID:
29554554
27.

Weight loss is associated with rapid striatal dopaminergic degeneration in Parkinson's disease.

Pak K, Shin HK, Kim EJ, Lee JH, Lyoo CH, Son J, Lee MJ.

Parkinsonism Relat Disord. 2018 Jun;51:67-72. doi: 10.1016/j.parkreldis.2018.02.044. Epub 2018 Feb 28.

PMID:
29510907
28.

Tau Positron Emission Tomography Imaging in Degenerative Parkinsonisms.

Lyoo CH, Cho H, Choi JY, Ryu YH, Lee MS.

J Mov Disord. 2018 Jan;11(1):1-12. doi: 10.14802/jmd.17071. Epub 2018 Jan 23. Review.

29.

Distinct patterns of amyloid-dependent tau accumulation in Lewy body diseases.

Lee SH, Cho H, Choi JY, Lee JH, Ryu YH, Lee MS, Lyoo CH.

Mov Disord. 2018 Feb;33(2):262-272. doi: 10.1002/mds.27252. Epub 2017 Nov 23.

PMID:
29168583
30.

Head to head comparison of [18F] AV-1451 and [18F] THK5351 for tau imaging in Alzheimer's disease and frontotemporal dementia.

Jang YK, Lyoo CH, Park S, Oh SJ, Cho H, Oh M, Ryu YH, Choi JY, Rabinovici GD, Kim HJ, Moon SH, Jang H, Lee JS, Jagust WJ, Na DL, Kim JS, Seo SW.

Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):432-442. doi: 10.1007/s00259-017-3876-0. Epub 2017 Nov 16.

31.

Brain regional iron contents in progressive supranuclear palsy.

Lee SH, Lyoo CH, Ahn SJ, Rinne JO, Lee MS.

Parkinsonism Relat Disord. 2017 Dec;45:28-32. doi: 10.1016/j.parkreldis.2017.09.020. Epub 2017 Sep 28.

PMID:
28982612
32.

18F-AV-1451 binds to motor-related subcortical gray and white matter in corticobasal syndrome.

Cho H, Baek MS, Choi JY, Lee SH, Kim JS, Ryu YH, Lee MS, Lyoo CH.

Neurology. 2017 Sep 12;89(11):1170-1178. doi: 10.1212/WNL.0000000000004364. Epub 2017 Aug 16.

PMID:
28814462
33.

Off-Target 18F-AV-1451 Binding in the Basal Ganglia Correlates with Age-Related Iron Accumulation.

Choi JY, Cho H, Ahn SJ, Lee JH, Ryu YH, Lee MS, Lyoo CH.

J Nucl Med. 2018 Jan;59(1):117-120. doi: 10.2967/jnumed.117.195248. Epub 2017 Aug 3.

34.

Parkinsonian Patients with Striatal Cribriform State Present Rapidly Progressive Axial Parkinsonism.

Lee SH, Lyoo CH, Cho H, Rinne JO, Lee MS.

Eur Neurol. 2017;78(3-4):119-124. doi: 10.1159/000479227. Epub 2017 Jul 26.

PMID:
28746923
35.

A Patient with Recurrent Dyskinesia and Hyperpyrexia Syndrome.

Baek MS, Lee HW, Lyoo CH.

J Mov Disord. 2017 Sep;10(3):154-157. doi: 10.14802/jmd.17022. Epub 2017 Jul 14.

36.

Paroxysmal freezing of gait in a patient with mesial frontal transient ischemic attacks.

Hwang HW, Lee SH, Lyoo CH, Lee MS.

BMC Neurol. 2017 Jun 28;17(1):122. doi: 10.1186/s12883-017-0901-7.

37.

18F-AV-1451 PET Imaging in Three Patients with Probable Cerebral Amyloid Angiopathy.

Kim HJ, Cho H, Werring DJ, Jang YK, Kim YJ, Lee JS, Lee J, Jun S, Park S, Ryu YH, Choi JY, Cho YS, Moon SH, Na DL, Lyoo CH, Seo SW.

J Alzheimers Dis. 2017;57(3):711-716. doi: 10.3233/JAD-161139.

PMID:
28282808
38.

Excessive tau accumulation in the parieto-occipital cortex characterizes early-onset Alzheimer's disease.

Cho H, Choi JY, Lee SH, Lee JH, Choi YC, Ryu YH, Lee MS, Lyoo CH.

Neurobiol Aging. 2017 May;53:103-111. doi: 10.1016/j.neurobiolaging.2017.01.024. Epub 2017 Feb 9.

PMID:
28254589
39.

Clinical Features Indicating Nigrostriatal Dopaminergic Degeneration in Drug-Induced Parkinsonism.

Lee SH, Kim HK, Lee YG, Lyoo CH, Ahn SJ, Lee MS.

J Mov Disord. 2017 Jan;10(1):35-39. doi: 10.14802/jmd.16045. Epub 2016 Dec 27.

40.

Distinct patterns of increased translocator protein in posterior cortical atrophy and amnestic Alzheimer's disease.

Kreisl WC, Lyoo CH, Liow JS, Snow J, Page E, Jenko KJ, Morse CL, Zoghbi SS, Pike VW, Turner RS, Innis RB.

Neurobiol Aging. 2017 Mar;51:132-140. doi: 10.1016/j.neurobiolaging.2016.12.006. Epub 2016 Dec 16.

41.

Impact of Prolonged Temporal Discrimination Threshold on Finger Movements of Parkinson's Disease.

Lee MJ, Son JS, Lee JH, Kim SJ, Lyoo CH, Lee MS.

PLoS One. 2016 Nov 28;11(11):e0167034. doi: 10.1371/journal.pone.0167034. eCollection 2016.

42.

A prognostic factor in focal hand dystonia: typist's cramp cases and literature review.

Ham JH, Kim SJ, Song SK, Lyoo CH, Lee PH, Sohn YH, Kang SY.

J Neurol Sci. 2016 Dec 15;371:85-87. doi: 10.1016/j.jns.2016.10.028. Epub 2016 Oct 19. Review.

PMID:
27871456
43.

18 F-AV-1451 binds to putamen in multiple system atrophy.

Cho H, Choi JY, Lee SH, Ryu YH, Lee MS, Lyoo CH.

Mov Disord. 2017 Jan;32(1):171-173. doi: 10.1002/mds.26857. Epub 2016 Nov 9. No abstract available.

PMID:
27859717
44.

Lack of association between LRRK2 G2385R and cognitive dysfunction in Korean patients with Parkinson's disease.

Hong JH, Kim YK, Park JS, Lee JE, Oh MS, Chung EJ, Kim JY, Sung YH, Lyoo CH, Lee JH, Kwon DY, Kim HS, Shin HW, Park SA, Park IS, Kim JS, Lee PH, Koh SB, Baik JS, Kim SJ, Ma HI, Kim JW, Kim YJ.

J Clin Neurosci. 2017 Feb;36:108-113. doi: 10.1016/j.jocn.2016.10.013. Epub 2016 Nov 10.

PMID:
27839916
45.

Subcortical 18 F-AV-1451 binding patterns in progressive supranuclear palsy.

Cho H, Choi JY, Hwang MS, Lee SH, Ryu YH, Lee MS, Lyoo CH.

Mov Disord. 2017 Jan;32(1):134-140. doi: 10.1002/mds.26844. Epub 2016 Nov 3.

PMID:
27813160
46.

Biodistribution and Radiation Dosimetry of [18F]Mefway in Humans.

Choi JY, Lyoo CH, Kim JS, Kim KM, Lee M, Ryu YH.

Mol Imaging Biol. 2016 Dec;18(6):803-806.

PMID:
27126460
47.

Delayed iron deposit and atrophy of the putamen in a case with osmotic demyelination syndrome.

Lee MS, Lee SH, Kim HK, Ahn SJ, Lyoo CH.

J Neurol Sci. 2016 Oct 15;369:131-133. doi: 10.1016/j.jns.2016.08.018. Epub 2016 Aug 9. No abstract available.

PMID:
27653878
48.

Comparison of two PET radioligands, [11C]FPEB and [11C]SP203, for quantification of metabotropic glutamate receptor 5 in human brain.

Lohith TG, Tsujikawa T, Siméon FG, Veronese M, Zoghbi SS, Lyoo CH, Kimura Y, Morse CL, Pike VW, Fujita M, Innis RB.

J Cereb Blood Flow Metab. 2017 Jul;37(7):2458-2470. doi: 10.1177/0271678X16668891. Epub 2016 Jan 1.

49.

Tau PET in Alzheimer disease and mild cognitive impairment.

Cho H, Choi JY, Hwang MS, Lee JH, Kim YJ, Lee HM, Lyoo CH, Ryu YH, Lee MS.

Neurology. 2016 Jul 26;87(4):375-83. doi: 10.1212/WNL.0000000000002892. Epub 2016 Jun 29.

PMID:
27358341
50.

In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum.

Cho H, Choi JY, Hwang MS, Kim YJ, Lee HM, Lee HS, Lee JH, Ryu YH, Lee MS, Lyoo CH.

Ann Neurol. 2016 Aug;80(2):247-58. doi: 10.1002/ana.24711. Epub 2016 Jul 8.

PMID:
27323247

Supplemental Content

Support Center